Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study
Phase 1 study is designed to provide clinical proof-of-concept by taking advantage of established methods in endocrinologySAN DIEGO, Feb. 03,...
Year: 2021
Outsourcing vs Inhouse Resourcing For Lateral Flow Test Manufacturing
Outsourcing vs Inhouse Resourcing For Lateral Flow Test Manufacturing New guide published by leading rapid test developer and manufacturer advises...
Sio Gene Therapies Announces First Patient Dosed in Clinical Trial of AXO-AAV-GM2 in Patients with Tay-Sachs and Sandhoff Disease (GM2 Gangliosidosis)
- First potentially disease-modifying gene therapy for GM2 gangliosidosis to enter clinical studies- Expect to continue patient identification, screening, and...
COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy
COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy Formal and scalable...
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2020 Financial Results, and Host Conference Call on February 10, 2021
REHOVOT, Israel, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived biopharmaceutical company, today announced that...
STERIS Announces Leadership Succession Plan
Walt Rosebrough to step down as CEO at the upcoming Annual General MeetingChief Operating Officer, Dan Carestio, to succeed as...
Kymera Therapeutics Strengthens Leadership with Key Appointments and Promotions
WATERTOWN, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation...
Coya Therapeutics Completes Merger with Nicoya Health Inc. and Announces $10 Million Series A Financing to Advance Pipeline of Regulatory T cell Therapeutics Optimized for Neurodegeneration and Autoimmune Diseases
-Seminal discoveries in regulatory T-cell (Treg) biology; Novel cryopreservation and manufacturing innovations based on the research of Stanley H. Appel,...
Humanigen and Avid Bioservices Enter into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing
BURLINGAME, Calif. and TUSTIN, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (“Avid”) and Humanigen, Inc. (NASDAQ:HGEN) (“Humanigen”)...
BioCryst Announces FDA Approval of Supplemental New Drug Application for RAPIVAB® Expanding Patient Population to Include Children Six Months and Older
RESEARCH TRIANGLE PARK, N.C., Feb. 03, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the U.S....
First Ever FDA Authorized Over-the-Counter At-Home Rapid Test Kit For Coronavirus Backed by Biden Administration, as Global WholeHealth Partners Corp. Pioneers The Only Biodegradable Plant Based Plastic for Medical Devices
San Clemente, CA, Feb. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp, (OTC:GWHP) a multinational medical...
Apria Announces Launch of Initial Public Offering
INDIANAPOLIS, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) announced today the launch of its initial...
Affimed Announces Collaboration with Roche to Study AFM24 in Combination with PD-L1 Checkpoint Inhibitor in EGFR Expressing Solid Tumors
Heidelberg, Germany, February 3, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their...
Chi-Med to Announce 2020 Final Results
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”)...
Tiziana Life Sciences CEO Discusses COVID-19 Trial Data in Exclusive Interview
NEW YORK and LONDON, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ:TLSA/LSE:TILS) ("Tiziana" or the "Company"), a biotechnology...
Biophytis Announces the Launch of its Proposed Public Offering and Nasdaq Listing
PARIS and CAMBRIDGE, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Biophytis (Euronext Growth Paris: ALBPS) (“Biophytis” or the “Company”), a...
Biophytis Announces the Start of Patient Recruitment in Brazil and the USA for Part 2 of the Phase 2-3 COVA Trial (“COVA Study”)
Patient recruitment in Part 2 of the COVA Study will begin in most clinical centers in Brazil and the United...
Izotropic Announces Upgrade to OTCQB Venture Market
Vancouver, British Columbia--(Newsfile Corp. - February 3, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the...
Model N Study: Improved Channel Data Optimizes Sales and Profitability for High-Tech and B2B Software Companies
Many Firms Lag in Implementing Technologies That Protect Revenue Streams and Margins, According to Research Commissioned by Cloud Revenue Management...
Establishment Labs Announces Participation in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the...